MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3350/cmh.2015.0040

Медицинская библиотека · Clinical and molecular hepatology · 2016

Mycophenolate mofetil as an alternative treatment for autoimmune hepatitis.

Park Seung Woon, Um Soon Ho, Lee Han Ah, Kim Sang Hyun, Sim Yura, Yim Sun Young, Seo Yeon Seok, Ryu Ho Sang

Клинический случайСтатьяПеревод пока не подготовлен

Аннотация

Autoimmune hepatitis (AIH) is an immune-mediated chronic liver disease characterized by hepatocellular inflammation, necrosis, and fibrosis, which can progress to cirrhosis and fulminant hepatic failure. The standard treatment for AIH includes corticosteroids alone or in combination with azathioprine. Although most patients achieve remission using the standard regimen, some patients do not respond due to either drug intolerance or refractory disease; in such cases alternative immunosuppressive agents should be explored. The second-line therapies are cyclophilin inhibitors such as cyclosporine A or tacrolimus, and nowadays mycophenolate mofetil (MMF) is widely used if azathioprine-based therapies are not tolerated. Although these are recommended as an alternative to the first-line regimen, there is insufficient evidence for the efficacy of second-line therapies, with the evidence based mainly on expert opinion. Therefore, we report an AIH patient receiving the standard regimen in whom remission did not occur due to side effects to azathioprine, but was successfully treated with MMF in combination with corticosteroids as an alternative to the standard regimen.

Для цитирования: Park Seung Woon, Um Soon Ho, Lee Han Ah, Kim Sang Hyun, Sim Yura, Yim Sun Young, Seo Yeon Seok, Ryu Ho Sang. Mycophenolate mofetil as an alternative treatment for autoimmune hepatitis.. Clinical and molecular hepatology. 2016. DOI: 10.3350/cmh.2015.0040.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.